Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Titel:
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Auteur:
Sridhar, Saranya Joaquin, Arnel Bonaparte, Matthew I Bueso, Agustin Chabanon, Anne-Laure Chen, Aiying Chicz, Roman M Diemert, David Essink, Brandon J Fu, Bo Grunenberg, Nicole A Janosczyk, Helene Keefer, Michael C Rivera M, Doris M Meng, Ya Michael, Nelson L Munsiff, Sonal S Ogbuagu, Onyema Raabe, Vanessa N Severance, Randall Rivas, Enrique Romanyak, Natalya Rouphael, Nadine G Schuerman, Lode Sher, Lawrence D Walsh, Stephen R White, Judith von Barbier, Dalia de Bruyn, Guy Canter, Richard Grillet, Marie-Helene Keshtkar-Jahromi, Maryam Koutsoukos, Marguerite Lopez, Denise Masotti, Roger Mendoza, Sandra Moreau, Catherine Ceregido, Maria Angeles Ramirez, Shelly Said, Ansoyta Tavares-Da-Silva, Fernanda Shi, Jiayuan Tong, Tina Treanor, John Diazgranados, Carlos A Savarino, Stephen